University of Florida
Gainesville, Florida, 32611, United States
NCT Number: NCT01842087
A single blind, six week dietary intervention will be conducted in order to evaluate the impact of fiber fortified foods on blood urea nitrogen, kidney function and quality of life in patients presenting with a moderate to severe decline in kidney function.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Gainesville, Florida, 32611, United States
Chronic Kidney Disease (CKD) patients may consume lower than recommended amounts of dietary fiber due to typical dietary habits, dietary restrictions, and uremic symptoms. A progressive decline in kidney function causes an accumulation of uremic molecules that contribute to further progression of the disease and reduced quality of life. In an effort to evaluate the impact of added fiber on blood urea nitrogen, kidney function and quality of life in patients presenting with a moderate to severe decline in kidney function (eGFR ≤ 50 mL/min/1.73 m2), a single blind, six week dietary intervention, clinical trial will be conducted.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Participants must:
Exclusion criteria
Participants must not:
For a period of 2 weeks, participants will consume control foods in addition to their usual diets.
Other names: Kellogg's Corn Pops, Publix Chocolate Chip Cookies, Kellogg's Special K Bar
For a period of 4 weeks, participants will consume food fortified with fiber in addition to their usual diets.
Other names: Kellogg's Corn Pops with Fiber, Weight Watchers Chocolate Chip Cookies, General Mills FiberOne Bar
Time frame: up to 42 days of the study
Blood samples (10 mL) will be taken on day 1, 14, 28, and 42. BUN will be assayed using the Urea Nitrogen Concentrated Reagent method.
Time frame: Days 1, 14, 28 and 42 of the study
eGFR will be calculated using the Modification of Diet in Renal Disease formula on days 1, 14, 28 and 42 of the study.
Time frame: Days 1, 14, 28 and 42 of the study
Serum creatinine will be assayed using the ADVIA Chemistry CRE_2c method.
Time frame: Daily
Participants will complete daily diaries to evaluate bowel movement frequency.
Time frame: Days 1, 14, 28 and 42
Participants will complete the Kidney Disease Quality of Life (KDQOL-36) questionnaire for 4 specific days during the study.
Time frame: Days 1, 14, 28 and 42 of the study
Time frame: Days 1, 14, 28 and 42 of the study
Time frame: Days 1, 14, 28 and 42 of the study
University of Florida
Other
An Investigation Into Pulse Fiber Fermentation and Nitrogen Excretion in Patients With Chronic Renal Failure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05021835
Cardiovascular Risk, Chronic Disease
Birmingham, Alabama, United States
View Trial DetailsNCT07195747
Arterial Occlusive Diseases, Arteriosclerosis
São Paulo, Brazil
View Trial DetailsNCT05254002
Chronic Disease, Chronic Kidney Disease
Surprise, Arizona, United States
View Trial DetailsNCT02579655
Brain Diseases, Cardiovascular Diseases
Calgary, Alberta, Canada
View Trial Details